Table 1:

Summary of NIST and PTSD Metabolites Detected by Vendors^[42]

Vendor	NIST Metabolitesa	Average Errorb	Error Rangec	PTSD Biomarkersd	Coveragee	Unique Metabolitesf	Percent Changeg
Biocrates	24	−19.29%	(−99.49% : 18.92%)	22	29%	0	−16%
HMT	13	−16.74%	(−38.5% : 1.97%)	48	63%	3	11%
Lipotype	1	−40.33%	N/A	24	32%	4	35%
Metabolon	N/A	N/A	N/A	53	70%	4	61%
Nightingale	12	−1.03%	(−19.63% : 15.25%)	12	16%	0	0%
Average	12.5	−19.35%	(−49.49% : 12.05%)	31.8	42%	-	-

^atotal number of metabolites detected by the vendor that matches known metabolites in the standard NIST plasma sample. The total number of known metabolites in the NIST plasma sample is 26.

^baverage error in the quantification of the detected NIST metabolites.

^cerror range in the quantification of the detected NIST metabolites.

N/A - not applicable; metabolon did not submit an analysis of the standard NIST plasma sample

^dtotal number of metabolites detected by the vendor that matches literature defined PTSD metabolite biomarkers. The total number of PTSD metabolite biomarkers identified from scientific literature is 76.

^epercentage of metabolites detected by the vendor that matches literature defined PTSD metabolite biomarkers.

^fthe number of PTSD metabolite biomarkers detected by the vendor that was not detected by any other vendor.

^gpercent change in the number of metabolites detected between two identical replicate sets of PTSD plasma samples.